fructose 2,6-diphosphate has been researched along with 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Almeida, A; BolaƱos, JP; Burmistrova, O; Eremeeva, T; Fedichev, PO; Jimenez-Blasco, D; Lapresa, R; Olias-Arjona, A; Romanov, S; Shishov, D; Zakurdaeva, K | 1 |
1 other study(ies) available for fructose 2,6-diphosphate and 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one
Article | Year |
---|---|
Targeting PFKFB3 alleviates cerebral ischemia-reperfusion injury in mice.
Topics: A549 Cells; Animals; Brain Ischemia; Cerebral Cortex; Disease Models, Animal; Enzyme Inhibitors; Fructosediphosphates; Gene Expression Regulation; Glutamic Acid; Glycolysis; Humans; Male; Mice; Neurons; Neuroprotective Agents; Pentose Phosphate Pathway; Phosphofructokinase-1; Phosphofructokinase-2; Primary Cell Culture; Proteasome Endopeptidase Complex; Proteolysis; Psychomotor Performance; Pyridines; Pyrrolidines; Reperfusion Injury | 2019 |